Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intensified pre-operative chemotherapy and radical surgery for high-risk hepatoblastoma
2006-001271-38Phase 2Completed
- Sponsor
- Our Lady's Children's Hospital, Crumlin
- Start
- May 2006
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of cisplatin, doxorubicin and dexrazoxane in hepatoblastoma, sponsored by Our Lady's Children's Hospital, Crumlin. Primary endpoints: Effectiveness and short-term toxicity of intensified chemotherapy, Overall survival and 1 more. Started May 2006; status: completed.
02
Drugs
cisplatindoxorubicindexrazoxane
03
Conditions
hepatoblastoma
Beyond the preview
Go deeper on 2006-001271-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-001271-38.